The European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study is part of the largest prospective evaluation of diet and health ever undertaken. The entire EPIC study involves ...
—Elevated HDL-C has been seen as protection from CVD. But this study, conducted in patients with CAD, seems to confirm other studies showing that in addition to low HDL-C levels (≤ 30 mg/dL), a very ...
Please provide your email address to receive an email when new articles are posted on . A gene present in 25% of the population, which reduces neuroprotective small HDL production, is associated with ...
Expert Rev Cardiovasc Ther. 2010;8(3):345-358. © 2010 Expert Reviews Ltd. Cite this: Implications of Torcetrapib Failure for the Future of HDL Therapy: Is HDL ...
We all know that it’s important to control your cholesterol, but the focus tends to be on the so-called “bad cholesterol” or LDL cholesterol. For most folks, their “good cholesterol” or HDL ...
Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
BOSTON, April 30, 2004 – Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results